A retrospective-prospective analysis of almost 16,000 patients in 5 different trials has demonstrated that the presence of stromal TILs at diagnosis is prognostic for TNBC and HER2+ BC, but not for luminal ER+ BC10. The gene discussed is ERBB2; the disease is breast cancer.